PEDIATRICS Vol. 99 No. 2 February 1997, pp. 268-278
AMERICAN ACADEMY OF PEDIATRICS:
"Inactive" Ingredients in Pharmaceutical Products: Update
(Subject Review)
Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded.
Statement of retirement:
- AAP Publications Retired, January 2004
Pediatrics 114: 506-506.[Full Text]
This article has been cited by other articles:
![]() |
S. A. Thomson, C. Tuleu, I. C. K. Wong, S. Keady, K. G. Pitt, and A. G. Sutcliffe Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children Pediatrics, February 1, 2009; 123(2): e235 - e238. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Lorenzoni and R. F. Wideman Jr. Intratracheal Administration of Bacterial Lipopolysaccharide Elicits Pulmonary Hypertension in Broilers with Primed Airways Poult. Sci., April 1, 2008; 87(4): 645 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benninger, J. G. Mastronarde, and M. C. Exline A 39-Year-Old Woman With Intractable Asthma Chest, October 1, 2007; 132(4): 1397 - 1400. [Full Text] [PDF] |
||||
![]() |
S.-W. Huang and P. R. Borum Study of Skin Rashes After Antibiotic Use in Young Children Clinical Pediatrics, October 1, 1998; 37(10): 601 - 607. [Abstract] [PDF] |
||||








